Moreover, in vitro studies have demonstrated the enhanced uptake of rhodamine labeled HA/PEI-decorated PLGA NPs in CD44+ lung cancer cells and improved DTX cytotoxic activity, compared to the free drug. Here, CD44 is linked to lung carcinoma.